A 24-year-old pregnant woman with inflammatory bowel disease.
Hou
Jason K
JK
Division of Gastroenterology, Baylor College of Medicine, Houston, Texas, USA.
Mahadevan
Uma
U
D000893:Anti-Inflammatory Agents / Q000009:adverse effects / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D001942:Breast Feeding; D003424:Crohn Disease / Q000150:complications* / Q000628:therapy*; D005260:Female; D005333:Fetus / Q000187:drug effects*; D006801:Humans; D007231:Infant, Newborn; D000069285:Infliximab; D008727:Methotrexate / Q000009:adverse effects / Q000627:therapeutic use; D011247:Pregnancy; D011248:Pregnancy Complications / Q000628:therapy*; D011256:Pregnancy Outcome; D011297:Prenatal Exposure Delayed Effects; D012074:Remission Induction; D018570:Risk Assessment; D013792:Thalidomide / Q000009:adverse effects / Q000627:therapeutic use; D055815:Young Adult
D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D013792:Thalidomide; D000069285:Infliximab; D008727:Methotrexate